ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för 15-deoxy-Delta(12,14)-prostaglandin J2. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

21 träffar

Bibliografisk träff 2009-06-03

15-Deoxy-Delta(12,14)-prostaglandin J2 induces IL-8 and GM-CSF in a human airway epithelial cell line (NCI-H292).

Chiba T, Ueki S, Ito W, Kato H, Takeda M, Kayaba H, Furue M, Chihara J.

Int Arch Allergy Immunol · research support, non-u.s. gov't; journal article · DOI 10.1159/000211377

Bibliografisk träff 2009-03-19

15-Deoxy-Delta12,14-prostaglandin J2 inhibits HIV-1 transactivating protein, Tat, through covalent modification.

Kalantari P, Narayan V, Henderson AJ, Prabhu KS.

FASEB J · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1096/fj.08-124982

Bibliografisk träff 2008-12-01

The 15-deoxy-delta 12,14-prostaglandin J2 suppresses monocyte chemoattractant protein-1 expression in IFN-gamma-stimulated astrocytes through induction of MAPK phosphatase-1.

Lee JH, Woo JH, Woo SU, Kim KS, Park SM, Joe EH, Jou I.

J Immunol · research support, non-u.s. gov't; journal article · DOI 10.4049/jimmunol.181.12.8642

Bibliografisk träff 2008-07-31

Cutaneous nociception evoked by 15-delta PGJ2 via activation of ion channel TRPA1.

Cruz-Orengo L, Dhaka A, Heuermann RJ, Young TJ, Montana MC, Cavanaugh EJ, Kim D, Story GM.

Mol Pain · comparative study; research-article; journal article · DOI 10.1186/1744-8069-4-30

Bibliografisk träff 2008-03-26

A natural PPAR-gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, may act as an enhancer of PAI-1 in human proximal renal tubular cells under hypoxic and inflammatory conditions.

Kimura H, Li X, Torii K, Okada T, Takahashi N, Fujii H, Ishihara S, Yoshida H.

Nephrol Dial Transplant · research support, non-u.s. gov't; journal article · DOI 10.1093/ndt/gfn139

Bibliografisk träff 2008-02-18

A novel activity for substance P: stimulation of peroxisome proliferator-activated receptor-gamma protein expression in human monocytes and macrophages.

Amoruso A, Bardelli C, Gunella G, Ribichini F, Brunelleschi S.

Br J Pharmacol · other; research support, non-u.s. gov't; journal article · DOI 10.1038/bjp.2008.50

Bibliografisk träff 2006-12-01

15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) and ciglitazone modulate Staphylococcus aureus-dependent astrocyte activation primarily through a PPAR-gamma-independent pathway.

Phulwani NK, Feinstein DL, Gavrilyuk V, Akar C, Kielian T.

J Neurochem · research-article; journal article; research support, n.i.h., extramural · DOI 10.1111/j.1471-4159.2006.04183.x

Bibliografisk träff 2006-09-23

Rosiglitazone inhibits angiotensin II-induced CTGF expression in vascular smooth muscle cells - role of PPAR-gamma in vascular fibrosis.

Gao DF, Niu XL, Hao GH, Peng N, Wei J, Ning N, Wang NP.

Biochem Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bcp.2006.09.019

Bibliografisk träff 2006-07-01

Effects of PPARgamma agonists on cell survival and focal adhesions in a Chinese thyroid carcinoma cell line.

Chen Y, Wang SM, Wu JC, Huang SH.

J Cell Biochem · research support, non-u.s. gov't; journal article · DOI 10.1002/jcb.20839

Bibliografisk träff 2006-01-18

15-Deoxy-Delta(12,14)-prostaglandin J(2) suppresses IL-6-induced STAT3 phosphorylation via electrophilic reactivity in endothelial cells.

Wung BS, Wu CC, Hsu MC, Hsieh CW.

Life Sci · research support, non-u.s. gov't; journal article · DOI 10.1016/j.lfs.2005.12.013

Bibliografisk träff 2005-04-08

Nanomolar and micromolar effects of 15-deoxy-delta 12,14-prostaglandin J2 on amnion-derived WISH epithelial cells: differential roles of peroxisome proliferator-activated receptors gamma and delta and nuclear factor kappa B.

Berry EB, Keelan JA, Helliwell RJ, Gilmour RS, Mitchell MD.

Mol Pharmacol · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1124/mol.104.009449

Bibliografisk träff 2005-03-04

Role of 15-deoxy delta(12,14) prostaglandin J2 and Nrf2 pathways in protection against acute lung injury.

Mochizuki M, Ishii Y, Itoh K, Iizuka T, Morishima Y, Kimura T, Kiwamoto T, Matsuno Y, Hegab AE, Nomura A, Sakamoto T, Uchida K, Yamamoto M, Sekizawa K.

Am J Respir Crit Care Med · comparative study; journal article · DOI 10.1164/rccm.200406-755oc

Bibliografisk träff 2005-03-01

Suppression of chondrosarcoma cells by 15-deoxy-Delta 12,14-prostaglandin J2 is associated with altered expression of Bax/Bcl-xL and p21.

Shen ZN, Nishida K, Doi H, Oohashi T, Hirohata S, Ozaki T, Yoshida A, Ninomiya Y, Inoue H.

Biochem Biophys Res Commun · journal article · DOI 10.1016/j.bbrc.2004.12.186

Bibliografisk träff 2004-11-23

Prostaglandin D(2) and J(2) induce apoptosis in human leukemia cells via activation of the caspase 3 cascade and production of reactive oxygen species.

Chen YC, Shen SC, Tsai SH.

Biochim Biophys Acta · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1016/j.bbamcr.2004.10.016

Bibliografisk träff 2004-10-01

Induction of reversible cysteine-targeted protein oxidation by an endogenous electrophile 15-deoxy-delta12,14-prostaglandin J2.

Ishii T, Uchida K.

Chem Res Toxicol · research support, non-u.s. gov't; journal article · DOI 10.1021/tx049860+

Bibliografisk träff 2003-08-11

Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.

Cuzzocrea S, Pisano B, Dugo L, Ianaro A, Patel NS, Di Paola R, Genovese T, Chatterjee PK, Di Rosa M, Caputi AP, Thiemermann C.

Br J Pharmacol · research-article; journal article · DOI 10.1038/sj.bjp.0705419

Bibliografisk träff 2002-05-01

The cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J(2) attenuates the development of acute and chronic inflammation.

Cuzzocrea S, Wayman NS, Mazzon E, Dugo L, Di Paola R, Serraino I, Britti D, Chatterjee PK, Caputi AP, Thiemermann C.

Mol Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1124/mol.61.5.997

Bibliografisk träff 2002-05-01

15-Deoxy-Delta(12,14)-prostaglandin J(2): the endogenous electrophile that induces neuronal apoptosis.

Kondo M, Shibata T, Kumagai T, Osawa T, Shibata N, Kobayashi M, Sasaki S, Iwata M, Noguchi N, Uchida K.

Proc Natl Acad Sci U S A · research support, non-u.s. gov't; research-article; journal article · DOI 10.1073/pnas.112212599

Bibliografisk träff 2002-01-01

Roles of peroxisome proliferator-activated receptor gamma in cardiovascular disease.

Takano H, Komuro I.

J Diabetes Complications · review; journal article · DOI 10.1016/s1056-8727(01)00203-3

Bibliografisk träff 2000-10-01

Bisphenol A diglycidyl ether (BADGE) is a PPARgamma agonist in an ECV304 cell line.

Bishop-Bailey D, Hla T, Warner TD.

Br J Pharmacol · other; research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; research support, u.s. gov't, non-p.h.s.; journal article · DOI 10.1038/sj.bjp.0703628

Bibliografisk träff 2000-01-01

The effect of activation of peroxisome proliferator-activated receptor gamma (PPARgamma) on human monocyte function: PPARgamma ligands do not inhibit tumor necrosis factor-alpha release in human monocytic cell line THP-1.

Naitoh T, Kitahara M, Tsuruzoe N.

Cell Biol Toxicol · journal article · DOI 10.1023/a:1007694110835